Percentage of biotech therapies in development as of 2017, by developer

Published by
Matej Mikulic,
Jan 30, 2018
This statistic displays the percentage of gene therapies and stem-cell therapies that were currently in clinical development as of 2017, by developer. According to the data, of the gene therapies in clinical development, only six percent were developed by Big Pharma.

Percentage of stem-cell and gene therapies in current development as of 2017, by developer

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

September 2017

Region

Worldwide

Survey time period

as of September 2017

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Cell and gene therapy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Cell and gene therapy

Market overview

6

R&D/trials

5

Stem cells

5

Cord blood

5

CAR/CAR-T

4

Miscellaneous

5

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Clinical trialsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu